X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

PLRX

Closed

Pliant Therapeutics inc

1.17
+0.01 (+0.86%)
Last Update: 01 Jul 2025 23:25:00
Yesterday: 1.16
Day's Range: 1.13 - 1.255
Send
When Written:
 
25.86
Pliant Therapeutics Inc. is a clinical-stage biopharmaceutical company that focuses on discovering and developing novel therapies for fibrotic diseases. The company's lead product candidate, PLN-74809, is a small molecule inhibitor of integrin αvβ1 that is being developed for the treatment of idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC). Pliant Therapeutics also has a pipeline of other product candidates targeting various fibrotic diseases, including liver fibrosis, kidney fibrosis, and skin fibrosis. The company was founded in 2016 and is headquartered in South San Francisco, California.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X